Preston Sprenkle

Memorial Sloan Kettering Cancer Center, Yale University

Papers

2

Total Citations

97

H-Index

2

About

Dr. Preston Sprenkle is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes for renal and prostate conditions. His major contributions lie in comparative effectiveness research for kidney cancer surgery and predictive modeling for post-operative complications. His landmark 2011 study, “Comparison of Open and Minimally Invasive Partial Nephrectomy for Renal Tumors 4–7 Centimeters,” which has garnered 95 citations, provided critical evidence that minimally invasive approaches can achieve oncologic equivalence to open surgery for larger, complex renal masses, helping to shift clinical practice toward nephron-sparing techniques. More recently, Dr. Sprenkle has advanced the field of functional urology by investigating whether preoperative pelvic MRI measurements can predict urinary incontinence following holmium laser enucleation of the prostate (HoLEP). This innovative 2025 work, though early in its citation life, addresses a pressing clinical question by applying anatomical insights from robotic prostatectomy to benign prostatic hyperplasia surgery. His research is characterized by a rigorous, evidence-based approach that directly informs surgical decision-making, improving both cancer control and quality of life for patients.

Research Focus

Key Achievements

2
H-Index
2
Papers
97
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Open and Minimally Invasive Partial Nephrectomy for Renal Tumors 4–7 Centimeters
95 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Memorial Sloan Kettering Cancer Center, Yale University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago